Skip to main content
OpenTrials

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

9,977 public trials 2,028 recruiting studies
Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Completed

Vorinostat and Bortezomib in Treating Young Patients With Refractory or Recurrent Solid Tumors, Including Central Nervous System Tumors and Lymphoma

NCT00994500

Conditions
Astrocytoma, Brain Diseases, Brain Neoplasms, +90 more
Locations
  • Childrens Memorial Hospital Chicago, Illinois, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Columbia University Medical Center New York, United States
  • Children's Hospital of Pittsburgh of UPMC Pittsburgh, Pennsylvania, United States
View Trial Details
Completed

Dolastatin 10 in Treating Patients With Indolent Lymphoma, Waldenstrom's Macroglobulinemia, or Chronic Lymphocytic Leukemia

NCT00005579

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +24 more
Locations
  • Marlene and Stewart Greenebaum Cancer Center, University of Maryland Baltimore, Maryland, United States
  • Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States
  • Arthur G. James Cancer Hospital - Ohio State University Columbus, Ohio, United States
  • Vermont Cancer Center Burlington, Vermont, United States
View Trial Details
Completed

Interferon Alfa Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Multiple Myeloma

NCT00003007

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • William F. Bowld Hospital Memphis, Tennessee, United States
  • Methodist Healthcare - Hospital of Memphis Memphis, Tennessee, United States
  • Baptist Memorial Hospital Memphis, Tennessee, United States
  • University of Tennessee, Memphis Memphis, Tennessee, United States
View Trial Details
Completed

Combination Chemotherapy Followed By Peripheral Stem Cell Transplantation or Isotretinoin in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Acute Lymphocytic Leukemia

NCT00003619

Conditions
Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +36 more
Locations
  • Medical College of Pennsylvania Hospital Philadelphia, Pennsylvania, United States
  • Medical College of Pennsylvania Philadelphia, Pennsylvania, United States
View Trial Details

Related conditions